Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Sci Rep. 2021 Nov 1;11(1):21382. doi: 10.1038/s41598-021-00362-y.
The cost of testing can be a substantial contributor to hepatitis C virus (HCV) elimination program costs in many low- and middle-income countries such as Georgia, resulting in the need for innovative and cost-effective strategies for testing. Our objective was to investigate the most cost-effective testing pathways for scaling-up HCV testing in Georgia. We developed a Markov-based model with a lifetime horizon that simulates the natural history of HCV, and the cost of detection and treatment of HCV. We then created an interactive online tool that uses results from the Markov-based model to evaluate the cost-effectiveness of different HCV testing pathways. We compared the current standard-of-care (SoC) testing pathway and four innovative testing pathways for Georgia. The SoC testing was cost-saving compared to no testing, but all four new HCV testing pathways further increased QALYs and decreased costs. The pathway with the highest patient follow-up, due to on-site testing, resulted in the highest discounted QALYs (123 QALY more than the SoC) and lowest costs ($127,052 less than the SoC) per 10,000 persons screened. The current testing algorithm in Georgia can be replaced with a new pathway that is more effective while being cost-saving.
检测成本可能是格鲁吉亚等许多低收入和中等收入国家丙型肝炎病毒 (HCV) 消除计划成本的主要贡献因素,因此需要创新和具有成本效益的检测策略。我们的目标是研究在格鲁吉亚扩大 HCV 检测的最具成本效益的检测途径。我们开发了一个具有终生时间范围的基于马尔可夫的模型,该模型模拟 HCV 的自然史以及 HCV 的检测和治疗成本。然后,我们创建了一个交互式在线工具,该工具使用基于马尔可夫的模型的结果来评估不同 HCV 检测途径的成本效益。我们比较了格鲁吉亚目前的标准护理 (SoC) 检测途径和四种创新检测途径。与不检测相比,SoC 检测具有成本节约,但所有四种新的 HCV 检测途径都进一步增加了 QALYs 并降低了成本。由于现场检测,具有最高患者随访率的途径导致每 10,000 人筛查的折扣 QALY(比 SoC 多 123 QALY)和成本(比 SoC 低 127,052 美元)最高。格鲁吉亚目前的检测算法可以用一种更有效且具有成本效益的新途径来替代。